CADILA HEALTHCARE LTD.

NSE : CADILAHCBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE410.300.95 (+0.23 %)
PREV CLOSE ( ) 409.35
OPEN PRICE ( ) 414.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 410.30 (473)
VOLUME 582694
TODAY'S LOW / HIGH ( )409.80 420.00
52 WK LOW / HIGH ( )329.95 558
NSE411.201.55 (+0.38 %)
PREV CLOSE( ) 409.65
OPEN PRICE ( ) 415.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 411.20 (422)
VOLUME 1041283
TODAY'S LOW / HIGH( ) 408.50 418.00
52 WK LOW / HIGH ( )328.8 560
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 15-05 1995
Management Info
Pankaj R Patel - Chairman Sharvil P Patel - Managing Director
Registered Office

Address Formulation Units,Zydus Tower,Satellite Cross Roads,
Ahmedabad,
Gujarat-380015

Phone 079- 26868100 /26868101 /26868102 /26868103 / 04 / 05 / 06 / 07 / 08 / 09 / 10 / 11 / 12 / 13 / 14 / 15 / 16 / 17 / 18 / 19 / 20

Email investor.grievance@zyduscadila.com

Website www.zyduscadila.com

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE, MCX
NEWS
14Dec Cadila Healthcare’s arm gets USFDA’s a
Cadila Healthcare’s wholly owned subsidiary Zydus Pharmaceuticals (USA)..
14Dec Cadila Healthcare’s arm gets USFDA’s a
Cadila Healthcare’s wholly owned subsidiary Zydus Pharmaceuticals (USA)..
08Dec Cadila Healthcare’s arm recalls 19,812
Cadila Healthcare’s arm - Zydus Pharmaceuticals USA Inc, is recalling 19..
08Dec Cadila Healthcare’s arm receives final
Cadila Healthcare’s wholly owned subsidiary - Zydus Pharmaceuticals (USA..
08Dec Cadila Healthcare gains on arm receivi
Cadila Healthcare is currently trading at Rs. 419.10, up by 2.00 points..
Financials
Rs. in Millions
QTR Sep 17 ANNUAL 17
Net Profit44986619
Gross Profit 6232 6422
Operating Profit 71749042
Net Sales 1738332745
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Dr. Reddys Lab (BSE)
 2372.00 (2.52%)
M.Cap (Rs. in Cr)39348.46
Merck (BSE)
 1211.35 (2.65%)
M.Cap (Rs. in Cr)2010.77
Torrent Pharma (BSE)
 1342.95 (2.13%)
M.Cap (Rs. in Cr)22725.77
Zandu Realty (BSE)
 1994.40 (1.39%)
M.Cap (Rs. in Cr)160.83
Pfizer (BSE)
 1995.70 (1.17%)
M.Cap (Rs. in Cr)9129.87
Shareholding Pattern
PROMOTERS 74.79%
NON-INSTITUTION 7.93%
MUTUAL FUNDS/UTI 3.83%
FI/BANKS/INSURANCE 3.6%
GOVERNMENT 0.08%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.